Drugs / Aerovant
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00801853 | Mar 2009 → Feb 2010 | asthma | Aerovance, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aerovant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00801853 ↗ |
| Route | Inhaled | “AEROVANT™ AER 001 Inhalation Powder” NCT00801853 ↗ |